Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Deenan Pillay; Jan Deenan; Silvia Bertagnolio; Charles Boucher; Francoise Brun-Vezinet; Bonaventura Clotet; Carlo Giaquinto; Carlo F. Perno

doi:10.3851/IMP2650

Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Deenan Pillay, Jan Deenan, Silvia Bertagnolio, Charles Boucher, Francoise Brun-Vezinet, Bonaventura Clotet, Carlo Giaquinto, Carlo F. Perno

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

12 Citations (Scopus)

Abstract

Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission. © 2013 International Medical Press 1359-6535 (print) 2040-2058 (online).

Original language	English
Pages (from-to)	831-836
Journal	Antiviral Therapy
Volume	18
Issue number	6
DOIs	https://doi.org/10.3851/IMP2650
Publication status	Published - 1 Dec 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.3851/IMP2650

Cite this

Pillay, D., Deenan, J., Bertagnolio, S., Boucher, C., Brun-Vezinet, F., Clotet, B., Giaquinto, C., & Perno, C. F. (2013). Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. Antiviral Therapy, 18(6), 831-836. https://doi.org/10.3851/IMP2650

@article{0e93095253234e13859eb78ed59ee521,

title = "Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network",

abstract = "Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission. {\textcopyright} 2013 International Medical Press 1359-6535 (print) 2040-2058 (online).",

author = "Deenan Pillay and Jan Deenan and Silvia Bertagnolio and Charles Boucher and Francoise Brun-Vezinet and Bonaventura Clotet and Carlo Giaquinto and Perno, \{Carlo F.\}",

year = "2013",

month = dec,

day = "1",

doi = "10.3851/IMP2650",

language = "English",

volume = "18",

pages = "831--836",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "Sage Publications",

number = "6",

}

Pillay, D, Deenan, J, Bertagnolio, S, Boucher, C, Brun-Vezinet, F, Clotet, B, Giaquinto, C & Perno, CF 2013, 'Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network', Antiviral Therapy, vol. 18, no. 6, pp. 831-836. https://doi.org/10.3851/IMP2650

Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. / Pillay, Deenan; Deenan, Jan; Bertagnolio, Silvia et al.
In: Antiviral Therapy, Vol. 18, No. 6, 01.12.2013, p. 831-836.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

AU - Pillay, Deenan

AU - Deenan, Jan

AU - Bertagnolio, Silvia

AU - Boucher, Charles

AU - Brun-Vezinet, Francoise

AU - Clotet, Bonaventura

AU - Giaquinto, Carlo

AU - Perno, Carlo F.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission. © 2013 International Medical Press 1359-6535 (print) 2040-2058 (online).

AB - Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission. © 2013 International Medical Press 1359-6535 (print) 2040-2058 (online).

UR - https://www.scopus.com/pages/publications/84890364624

U2 - 10.3851/IMP2650

DO - 10.3851/IMP2650

M3 - Article

SN - 1359-6535

VL - 18

SP - 831

EP - 836

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 6

ER -

Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this